Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Kim

Showing results (321-330 of 513) with videos related to

Pageof 52
Sort By:
Administration and Policy in Mental Health|October 25, 2018
Assessing Collaborative Care in Mental Health Teams: Qualitative Analysis to Guide Future ImplementationChristopher J Miller, Jennifer L Sullivan, Bo Kim, et al.
BMJ Open|February 6, 2025
Korean patients with hereditary cancer: a prospective multicentre cohort study protocol exploring psychosocial and health outcomesJun-Kyu Kim, Mi-Ae Jang, Jong Eun Park, et al.
International Journal of Alzheimer'S Disease|April 5, 2011
Resting-state glucose metabolism level is associated with the regional pattern of amyloid pathology in Alzheimer's diseaseJonghan Shin, Wai Tsui, Yi Li, et al.
BMC Primary Care|March 8, 2025
Determinants of implementation of continuous glucose monitoring for patients with Insulin-Treated type 2 diabetes: a national survey of primary care providersVarsha G Vimalananda, Ben Kragen, Alison J Leibowitz, et al.
Health & Justice|March 28, 2019
A novel application of process mapping in a criminal justice setting to examine implementation of peer support for veterans leaving incarcerationBo Kim, Megan B McCullough, Molly M Simmons, et al.
Plos One|September 17, 2013
PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancerJi Eun Park, Lin Ao, Zachary Miller, et al.
Journal of Medicinal Chemistry|April 10, 2019
Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and BortezomibMin Jae Lee, Deepak Bhattarai, Jisu Yoo, et al.
Molecular Diagnosis & Therapy|September 18, 2021
Correction to: Analytical and Clinical Performance of Droplet Digital PCR in the Detection and Quantification of SARS-CoV-2Kyoung Bo Kim, Hayoung Choi, Gun Dong Lee, et al.
Bioorganic & Medicinal Chemistry|July 12, 2011
A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probesKimberly Cornish Carmony, Do-Min Lee, Ying Wu, et al.
The Journal of Physical Chemistry. B|September 4, 2010
Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulationsBeilei Lei, Mohamed Diwan M Abdul Hameed, Adel Hamza, et al.
Pageof 52

Showing results (321-330 of 513) with videos related to

Sort By:
Pageof 52
Administration and Policy in Mental Health|October 25, 2018
Assessing Collaborative Care in Mental Health Teams: Qualitative Analysis to Guide Future ImplementationChristopher J Miller, Jennifer L Sullivan, Bo Kim, et al.
BMJ Open|February 6, 2025
Korean patients with hereditary cancer: a prospective multicentre cohort study protocol exploring psychosocial and health outcomesJun-Kyu Kim, Mi-Ae Jang, Jong Eun Park, et al.
International Journal of Alzheimer'S Disease|April 5, 2011
Resting-state glucose metabolism level is associated with the regional pattern of amyloid pathology in Alzheimer's diseaseJonghan Shin, Wai Tsui, Yi Li, et al.
BMC Primary Care|March 8, 2025
Determinants of implementation of continuous glucose monitoring for patients with Insulin-Treated type 2 diabetes: a national survey of primary care providersVarsha G Vimalananda, Ben Kragen, Alison J Leibowitz, et al.
Health & Justice|March 28, 2019
A novel application of process mapping in a criminal justice setting to examine implementation of peer support for veterans leaving incarcerationBo Kim, Megan B McCullough, Molly M Simmons, et al.
Plos One|September 17, 2013
PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancerJi Eun Park, Lin Ao, Zachary Miller, et al.
Journal of Medicinal Chemistry|April 10, 2019
Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and BortezomibMin Jae Lee, Deepak Bhattarai, Jisu Yoo, et al.
Molecular Diagnosis & Therapy|September 18, 2021
Correction to: Analytical and Clinical Performance of Droplet Digital PCR in the Detection and Quantification of SARS-CoV-2Kyoung Bo Kim, Hayoung Choi, Gun Dong Lee, et al.
Bioorganic & Medicinal Chemistry|July 12, 2011
A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probesKimberly Cornish Carmony, Do-Min Lee, Ying Wu, et al.
The Journal of Physical Chemistry. B|September 4, 2010
Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulationsBeilei Lei, Mohamed Diwan M Abdul Hameed, Adel Hamza, et al.
Pageof 52